When lifestyle intervention and oral antidiabetic drugs (OADs) fail to provide optimal control, patients with type 2 diabetes are required to initiate injectable therapies, mostly basal insulin (BI), according to 2020 Chinese guidelines for T2DM management [5]. Here, INS is linked to type 2 diabetes mellitus.